188 related articles for article (PubMed ID: 22149969)
1. An evolving web of signaling networks regulated by Cripto-1.
Nagaoka T; Karasawa H; Castro NP; Rangel MC; Salomon DS; Bianco C
Growth Factors; 2012 Feb; 30(1):13-21. PubMed ID: 22149969
[TBL] [Abstract][Full Text] [Related]
2. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
Strizzi L; Bianco C; Normanno N; Salomon D
Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
[TBL] [Abstract][Full Text] [Related]
3. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
[TBL] [Abstract][Full Text] [Related]
4. Alantolactone inhibits cell proliferation by interrupting the interaction between Cripto-1 and activin receptor type II A in activin signaling pathway.
Shi Y; Bao YL; Wu Y; Yu CL; Huang YX; Sun Y; Zheng LH; Li YX
J Biomol Screen; 2011 Jun; 16(5):525-35. PubMed ID: 21378277
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cells are regulated by Cripto, as an intermediary of HIF-1α in the hypoxic bone marrow niche.
Miharada K; Karlsson G; Rehn M; Rörby E; Siva K; Cammenga J; Karlsson S
Ann N Y Acad Sci; 2012 Aug; 1266():55-62. PubMed ID: 22901256
[TBL] [Abstract][Full Text] [Related]
6. Cripto-1: an embryonic gene that promotes tumorigenesis.
de Castro NP; Rangel MC; Nagaoka T; Salomon DS; Bianco C
Future Oncol; 2010 Jul; 6(7):1127-42. PubMed ID: 20624125
[TBL] [Abstract][Full Text] [Related]
7. Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis.
Gray PC; Vale W
FEBS Lett; 2012 Jul; 586(14):1836-45. PubMed ID: 22306319
[TBL] [Abstract][Full Text] [Related]
8. The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.
Klauzinska M; Castro NP; Rangel MC; Spike BT; Gray PC; Bertolette D; Cuttitta F; Salomon D
Semin Cancer Biol; 2014 Dec; 29():51-8. PubMed ID: 25153355
[TBL] [Abstract][Full Text] [Related]
9. An antibody-cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumours.
Kelly RK; Olson DL; Sun Y; Wen D; Wortham KA; Antognetti G; Cheung AE; Orozco OE; Yang L; Bailly V; Sanicola M
Eur J Cancer; 2011 Jul; 47(11):1736-46. PubMed ID: 21458984
[TBL] [Abstract][Full Text] [Related]
10. Cripto-1: an extracellular protein - connecting the sequestered biological dots.
Klauzinska M; Bertolette D; Tippireddy S; Strizzi L; Gray PC; Gonzales M; Duroux M; Ruvo M; Wechselberger C; Castro NP; Rangel MC; Focà A; Sandomenico A; Hendrix MJ; Salomon D; Cuttitta F
Connect Tissue Res; 2015; 56(5):364-80. PubMed ID: 26327334
[TBL] [Abstract][Full Text] [Related]
11. Cripto monoclonal antibodies.
Hu XF; Xing PX
Drug News Perspect; 2005 Jun; 18(5):293-303. PubMed ID: 16193101
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and Cellular Analysis Reveals Ligand Binding Specificities, a Molecular Basis for Ligand Recognition, and Membrane Association-dependent Activities of Cripto-1 and Cryptic.
Aykul S; Parenti A; Chu KY; Reske J; Floer M; Ralston A; Martinez-Hackert E
J Biol Chem; 2017 Mar; 292(10):4138-4151. PubMed ID: 28126904
[TBL] [Abstract][Full Text] [Related]
13. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.
Kelber JA; Panopoulos AD; Shani G; Booker EC; Belmonte JC; Vale WW; Gray PC
Oncogene; 2009 Jun; 28(24):2324-36. PubMed ID: 19421146
[TBL] [Abstract][Full Text] [Related]
14. Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo.
Liguori GL; Borges AC; D'Andrea D; Liguoro A; Gonçalves L; Salgueiro AM; Persico MG; Belo JA
Dev Biol; 2008 Mar; 315(2):280-9. PubMed ID: 18241853
[TBL] [Abstract][Full Text] [Related]
15. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.
Gray PC; Shani G; Aung K; Kelber J; Vale W
Mol Cell Biol; 2006 Dec; 26(24):9268-78. PubMed ID: 17030617
[TBL] [Abstract][Full Text] [Related]
16. TGF-β superfamily member Nodal stimulates human β-cell proliferation while maintaining cellular viability.
Boerner BP; George NM; Targy NM; Sarvetnick NE
Endocrinology; 2013 Nov; 154(11):4099-112. PubMed ID: 23970788
[TBL] [Abstract][Full Text] [Related]
17. Non-cell-autonomous role for Cripto in axial midline formation during vertebrate embryogenesis.
Chu J; Ding J; Jeays-Ward K; Price SM; Placzek M; Shen MM
Development; 2005 Dec; 132(24):5539-51. PubMed ID: 16291788
[TBL] [Abstract][Full Text] [Related]
18. Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model.
Alam MJ; Takahashi R; Afify SM; Oo AKK; Kumon K; Nawara HM; Khayrani AC; Du J; Zahra MH; Seno A; Salomon DS; Seno M
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373174
[TBL] [Abstract][Full Text] [Related]
19. Administration of Cripto in GRP78 overexpressed human MSCs enhances stem cell viability and angiogenesis during human MSC transplantation therapy.
Kim S; Yoon YM; Han YS; Lee JH; Hur J; Lee SH
Cell Prolif; 2018 Oct; 51(5):e12463. PubMed ID: 29722092
[TBL] [Abstract][Full Text] [Related]
20. Role of Cripto-1 in stem cell maintenance and malignant progression.
Bianco C; Rangel MC; Castro NP; Nagaoka T; Rollman K; Gonzales M; Salomon DS
Am J Pathol; 2010 Aug; 177(2):532-40. PubMed ID: 20616345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]